Skip to main content
Andrew Concoff, MD, Rheumatology, Fullerton, CA

Andrew Louis Concoff MD

Osteoarthritis


Physician

Join to View Full Profile
  • 2141 N Harbor BlvdSte 35000Fullerton, CA 92835

  • Phone+1 714-626-8630

  • Fax+1 714-626-8659

Dr. Concoff is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Sports Medicine (Family Medicine), 1999 - 2001
  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1994 - 1996
  • McGovern Medical School at UTHealth
    McGovern Medical School at UTHealthClass of 1994

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1996 - 2025
  • TX State Medical License
    TX State Medical License 2001 - 2004

Awards, Honors, & Recognition

  • CAQ, Sports Medicine ABIM
  • CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2011-2012
  • Fellow (FACR) American College of Rheumatology

Publications & Presentations

PubMed

Authored Content

  • A Urinary Biomarker Panel to Predict the Probability of Histologically Active Lupus NephritisNovember 2024

Press Mentions

  • Precision Medicine on a Population Level
    Precision Medicine on a Population LevelFebruary 6th, 2025
  • Precision Medicine on a Population Level: Can Digital Health Technology Improve Access to Rheumatologic Care?
    Precision Medicine on a Population Level: Can Digital Health Technology Improve Access to Rheumatologic Care?January 16th, 2025
  • Rheumatology Patients Are Still Struggling with Shortages of Actemra, a Medication Being Used to Treat COVID-19
    Rheumatology Patients Are Still Struggling with Shortages of Actemra, a Medication Being Used to Treat COVID-19January 19th, 2022
  • Join now to see all

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: